Explore the Value of Supporting Working Caregivers

Employers are increasingly recognizing the hidden costs and human impact of pediatric chronic conditions on their workforce.

The insights below summarize how the Adhera Caring Digital Program (ACDP) helps families manage conditions like Type 1 diabetes, obesity, asthma, autism, growth hormone deficiency, epilepsy, and pediatric cancer - and the measurable return this creates for employers.

If what you read resonates, Adhera can provide a detailed ROI analysis tailored to your company and a live demo of the ACDP platform to show how it supports employees and their families in real time.

Adhera Health | Pediatric Chronic Conditions Value Summary
Adhera Caring Digital Program

Value for Employers: Supporting Working Parents of Children with Pediatric Chronic Conditions

Adhera Caring delivers measurable improvements in caregiver well‑being, adherence, and retention — translating into meaningful reductions in turnover, absenteeism, and avoidable acute care.

1) Scope & Employee Impact (Example: 5,000 employees)

  • 10–15 parents of children with Type 1 Diabetes
  • ~680–760 parents of children with obesity / metabolic disorders
  • 15–32 parents of children with severe asthma
  • 100–111 parents of children with autism
  • Smaller cohorts with epilepsy, growth hormone deficiency, and pediatric cancer

These families experience higher stress and time demands — leading to absenteeism, reduced productivity, and elevated turnover risk.

Conditions Included

Type 1 Diabetes Severe Asthma Obesity / Metabolic Autism / Neurodevelopmental Growth Hormone Deficiency Epilepsy Pediatric Cancer

2) Value Levers by Condition

ConditionMajor Burden TypeKey Intervention Opportunity
Type 1 DiabetesHospitalizations, acute crisesKnowledge + goal support; proactive monitoring
Severe AsthmaER visits, exacerbationsAdherence, trigger control, action plans
Obesity / MetabolicBehavioral + comorbidity riskPersonalized behavior change; family routines
Autism / NeurodevelopmentalCaregiver burnout; crisesCoping tools, structured planning, resilience
Growth Hormone DeficiencyTherapy adherence; psychosocial stressCaregiver guidance; adherence support
Epilepsy / Pediatric CancerAcute episodes; complex careStress mitigation; coordination; navigation

3) Adhera Evidence (Peer‑Reviewed)

📈
Type 1 Diabetes (JMIR Pediatrics & Parenting)

Study showed increased positive affect; reductions in stress, anxiety, depression; improved self‑efficacy and well‑being.

💬
Growth Hormone Therapy (JMIR Pediatrics & Parenting)

Study found high usability, 91% of parents moved from severe depression to normal depression, 80% of children in suboptimal adherence group moved to optimal adherence group. Parents reported improvements in parent‑child relationship.

4) Employer ROI Drivers

  • Reduced turnover among caregiver employees
  • Lower absenteeism / presenteeism
  • Avoided emergency & hospitalization costs
  • Higher productivity & engagement
  • Improved caregiver mental health & resilience
Example (5,000 employees): If ~1% are caregiver‑employees and average salary is $60K, a 20% reduction in caregiver turnover can save ≈ $900K annually; 30–50% lower absenteeism adds further savings.

5) Organizational Impact Summary

CategoryMeasured ImpactEstimated Employer Savings
Turnover Reduction20–25% fewer caregiver exits$300K–$900K annually
Absenteeism30–50% reduction$40K–$100K+
Healthcare Utilization30–45% fewer acute eventsVariable offsets
Productivity+5–10% gainQualitative ROI

References

  1. Norris S.L., Engelgau M.M., Narayan K.M.V. Diabetes Care (2001).
  2. Powers M.A., Bardsley J., Cypress M., et al. Diabetes Care (2015).
  3. JMIR Pediatrics & Parenting (T1D Study), 2024.
  4. JMIR Pediatrics & Parenting (GHD Study), 2025.
  5. Perry R. et al. The Economic Burden of Pediatric Asthma in the U.S., 2018.
  6. CDC. Additional Medical Expenditures Associated with Treated Asthma in Children, 2024.
  7. Yang F. et al. Caregiver Burden in Pediatric Asthma, 2024.
  8. Georgetown HPI. Workers Affected by Chronic Conditions, 2023.
  9. CDC. Childhood Obesity in the United States, 2024.